NCT02973412
Chronotype of Patients With Diabetes and Effect on Glycaemic Control
Recruiting · Not specified · University of Leicester · registry updated 2024-02-15
Inclusion and exclusion lines below are quoted from ClinicalTrials.gov. No match score is shown, because a score needs a person's age, biomarkers, and treatment dates. Confirm the record with the study team.
The aim of this study is to explore the associations between chronotype and glycaemic control, cardiometabolic health and other lifestyle factors.
Inclusion
- Participant is willing and able to give informed consent for participation in the study
- T1DM or established T2DM (\>6months since diagnosis)
- Male or Female
- Aged 18-75 years inclusive
- BMI less than or equal to 45kg/m² inclusive
- No known sleep disorders except Obstructive Sleep Apnoea (OSA)
Exclusion
- Participant is unwilling or unable to give informed consent
- Anyone without a good command of the English language
- Anyone \<18 years of age and \>75 years of age
- BMI greater than 45 kg/m²
- A regular cannabis user i.e. weekly use
- Have a terminal illness